NCT04762459 2022-02-24
APEX
ChineseAMS
Phase 3 Enrolling by invitation
Clinical Trials
4 trialsNCT03636685 2018-08-17
Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC
ChineseAMS
Phase 1/2 Unknown
NCT02829008 2016-07-12
Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients
ChineseAMS
Phase 2 Unknown
NCT01143974 2013-03-14
Trial of Pemetrexed in Combined With Cisplatin for the Treatment of Advanced Breast Cancer
ChineseAMS
Phase 4 Completed